ADORA3 and cancer: Drug combinations in clinical oncology aim to target cancer cells at multiple levels to improve therapeutic efficacy and clinical outcome.42, 43, 44 Thus, besides the above-suggested consideration of ADORA3 expression levels in liver tumors, it is of interest to identify drugs suited for combination treatment.